Martin B. Finkelstein

Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies

Wenyue Hu, Tae Sung, Bart Jessen et al. · Clinical Cancer Research · 2015 · 163 citations

Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.

Jean S. Beebe, Jitesh P. Jani, Elisabeth Knauth et al. · PubMed · 2003 · 128 citations

Cancer Therapy, Pharmacological Characterization, Tumor Biology +21

Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors

Changhua Ji, Marc D. Roy, Jonathan Golas et al. · Clinical Cancer Research · 2019 · 118 citations

Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model

Changhua Ji, Mausumee Guha, Xu Zhu et al. · Chemical Research in Toxicology · 2019 · 47 citations

Allergy Medicine, Skin Rash, Allergen +19

PF-06804103, A Site-specific Anti-HER2 Antibody–Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers

Edmund I. Graziani, Matthew Sung, Dangshe Ma et al. · Molecular Cancer Therapeutics · 2020 · 45 citations